Bank of New York Mellon
AGL icon

Bank of New York Mellon’s Agilon Health AGL Stock Holding History

Bank of New York Mellon’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79M Buy
35,336
+3,074
+10% +$201K ﹤0.01% 2603
2026
Q1 		$255K Sell
32,262
-1,202
-4% -$19.4K ﹤0.01% 3913
2025
Q4 		$576K Sell
33,464
-591
-2% -$11.5K ﹤0.01% 3521
2025
Q3 		$877K Buy
34,055
+1,066
+3% +$40.3K ﹤0.01% 3282
2025
Q2 		$1.9M Buy
32,989
+679
+2% +$54.5K ﹤0.01% 2780
2025
Q1 		$3.5M Buy
32,310
+1,318
+4% +$115K ﹤0.01% 2407
2024
Q4 		$1.47M Sell
30,992
-3,086
-9% -$187K ﹤0.01% 2904
2024
Q3 		$3.35M Sell
34,078
-10,279
-23% -$1.33M ﹤0.01% 2499
2024
Q2 		$7.25M Buy
44,357
+6,995
+19% +$996K ﹤0.01% 2134
2024
Q1 		$5.7M Sell
37,362
-4,685
-11% -$780K ﹤0.01% 2266
2023
Q4 		$13.2M Buy
42,047
+231
+0.6% +$83.6K ﹤0.01% 1826
2023
Q3 		$18.6M Buy
41,816
+2,468
+6% +$1.11M ﹤0.01% 1583
2023
Q2 		$17.1M Buy
39,348
+11,163
+40% +$6.27M ﹤0.01% 1640
2023
Q1 		$16.7M Buy
28,185
+1,319
+5% +$739K ﹤0.01% 1647
2022
Q4 		$10.8M Sell
26,866
-473
-2% -$222K ﹤0.01% 1898
2022
Q3 		$16M Buy
27,339
+8,210
+43% +$4.92M ﹤0.01% 1629
2022
Q2 		$10.4M Buy
19,129
+3,502
+22% +$1.77M ﹤0.01% 1909
2022
Q1 		$9.9M Buy
15,627
+15
+0.1% +$7.73K ﹤0.01% 2071
2021
Q4 		$10.5M Buy
15,612
+8,618
+123% +$5.24M ﹤0.01% 2075
2021
Q3 		$4.58M Buy
6,994
+1,290
+23% +$1.1M ﹤0.01% 2533
2021
Q2 		$5.79M Buy
+5,704
New +$5M ﹤0.01% 2416

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
SSA
Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Bank of New York Mellon's AGL Position: Q2 2026 in Review

Bank of New York Mellon increased its Agilon Health (AGL) stake by 9.5% in Q2 2026, buying an estimated $201K and bringing the position to 35,336 shares worth $3.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

Bank of New York Mellon first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. The position peaked at $18.6M in Q3 2023. 68 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Bank of New York Mellon held 35,336 shares of Agilon Health worth $3.79M as of Q2 2026.
  • Bank of New York Mellon bought 3,074 Agilon Health shares in Q2 2026, an estimated $201K.
  • Agilon Health made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2603 holding.
  • Bank of New York Mellon first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
  • Bank of New York Mellon's Agilon Health position peaked at $18.6M in Q3 2023.
  • 68 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.